Literature DB >> 2254302

Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity.

Y B Xie1, H Wang, D L Segaloff.   

Abstract

The lutropin-choriogonadotropin (LH/CG) receptor is a cell surface receptor comprised of two domains of roughly equivalent size. The amino-terminal half of the receptor is relatively hydrophilic and is located extracellularly, whereas the carboxyl-terminal half of the receptor shares amino acid homology with other receptors that couple to G proteins and is similarly thought to span the plasma membrane seven times, ending with a relatively short carboxyl-terminal tail. In order to test the role of the extracellular domain in binding hormone, we constructed a mutated rat luteal LH/CG receptor cDNA (termed pCLHR-D2), which encodes for only the extracellular domain, and used it to transiently transfect human kidney 293 cells. Here we report that the expressed extracellular domain of the LH/CG receptor is capable of binding human CG with a high affinity, comparable with that of the full-length receptor. Thus, not only is the extracellular domain of the glycoprotein hormone receptors involved in binding hormone, but it alone is capable of conferring high affinity binding. Unexpectedly, it was also found that this truncated receptor is not secreted into the culture media but remains trapped within the cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254302

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Revisiting and questioning functional rescue between dimerized LH receptor mutants.

Authors:  Meilin Zhang; Rongbin Guan; Deborah L Segaloff
Journal:  Mol Endocrinol       Date:  2012-03-08

2.  Receptor binding dependent structural changes in human choriogonadotropin: photochemical inter-subunit crosslinking.

Authors:  I Ji; Y N Pan; Y M Lee; T Phang; T H Ji
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

3.  Activation of membrane receptors.

Authors:  T H Ji; W J Murdoch; I Ji
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

4.  Ligand-induced receptor dimerization may be critical for signal transduction by choriogonadotropin.

Authors:  N Grewal; S Nagpal; G B Chavali; S S Majumdar; R Pal; D M Salunke
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

5.  Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor.

Authors:  G X Xie; F Meng; A Mansour; R C Thompson; M T Hoversten; A Goldstein; S J Watson; H Akil
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

7.  Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

Authors:  S J Siciliano; T E Rollins; J DeMartino; Z Konteatis; L Malkowitz; G Van Riper; S Bondy; H Rosen; M S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

8.  A G protein-coupled receptor with low density lipoprotein-binding motifs suggests a role for lipoproteins in G-linked signal transduction.

Authors:  C P Tensen; E R Van Kesteren; R J Planta; K J Cox; J F Burke; H van Heerikhuizen; E Vreugdenhil
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Cloning and pharmacological characterization of a rat kappa opioid receptor.

Authors:  F Meng; G X Xie; R C Thompson; A Mansour; A Goldstein; S J Watson; H Akil
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  Luteinizing hormone receptor ectodomain splice variant misroutes the full-length receptor into a subcompartment of the endoplasmic reticulum.

Authors:  Pirjo M Apaja; Jussi T Tuusa; E Maritta Pietilä; Hannu J Rajaniemi; Ulla E Petäjä-Repo
Journal:  Mol Biol Cell       Date:  2006-02-22       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.